SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 175 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $336,000 | -19.8% | 20,000 | 0.0% | 0.02% | -21.7% |
Q2 2018 | $419,000 | -13.3% | 20,000 | -33.3% | 0.02% | -14.8% |
Q1 2018 | $483,000 | -15.1% | 30,000 | 0.0% | 0.03% | -12.9% |
Q4 2017 | $569,000 | +34.8% | 30,000 | 0.0% | 0.03% | +34.8% |
Q3 2017 | $422,000 | +110.0% | 30,000 | +20.0% | 0.02% | +53.3% |
Q2 2017 | $201,000 | – | 25,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,177,115 | $1,518,000 | 1.37% |
CM Management, LLC | 600,000 | $774,000 | 0.65% |
ARMISTICE CAPITAL, LLC | 17,100,000 | $22,059,000 | 0.43% |
Sargent Investment Group, LLC | 414,600 | $535,000 | 0.14% |
Ergoteles LLC | 299,005 | $386,000 | 0.02% |
Sonora Investment Management Group, LLC | 82,000 | $106,000 | 0.01% |
MCDONALD PARTNERS LLC | 42,570 | $55,000 | 0.01% |
CAXTON ASSOCIATES LP | 107,135 | $138,000 | 0.01% |
Crestline Management, LP | 66,209 | $85,000 | 0.01% |
D. E. Shaw & Co., Inc. | 7,845,726 | $10,121,000 | 0.01% |